Head of Specialty Therapeutics

At Life Stance Health, we believe in a truly healthy society where mental and physical healthcare are unified to make lives better. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable, and personalized mental healthcare. Everywhere. Every day. It’s a lofty goal; we know. But we make it happen with the best team in behavioral health.

Thank you for taking the time to explore a career with us. As the fastest growing behavioral health practice group in the country, now is the perfect time to join our clinical team!

The role will be a clinical authority on neuromodulation and emerging pharmacotherapies (including esketamine, ketamine, and psychedelic-assisted therapies) while overseeing safe, evidence-based program development with the goal of positioning Life Stance as a national leader in interventional psychiatry.

This role is responsible for advancing specialty and interventional psychiatric therapeutics by developing protocols, training, quality standards, and outcome measures to support patients. Success looks like safe, evidence-based, responsibly scaled specialty therapeutic programs that improve outcomes and align with enterprise clinical and operational priorities.

This role is part of a team who will be assisting with implementing the and guiding the directives of the CMO team. We are seeking a highly collaborative, mission-driven professional with strong emotional intelligence, sound judgment, and exceptional executive functioning. The ideal candidate is a mature and efficient team player who communicates thoughtfully, remains solutions-oriented under pressure, and consistently puts shared goals above personal agenda.

This person should be energized by the opportunity to help shape the future of mental healthcare and thrive in a high-accountability environment built on trust, focus, and mutual respect.

Consistent with Life Stance’s values, every member of the Life Stance team is expected to support each other and the mission, which may mean participating in projects and initiatives and performing functions and responsibilities not specifically outlined in this job description.

• Design and implement an enterprise interventional psychiatry strategy encompassing TMS (including rapid protocols), emerging pharmacotherapies, and neuromodulation modalities.

• Lead clinical program development for psychedelic-assisted therapies (including psilocybin, MDMA, and other emerging agents) in alignment with current and future FDA guidance and DEA regulatory requirements

• Evaluate emerging specialty treatments using current evidence, regulatory requirements, safety considerations, operational feasibility, and patient need.

• Monitor and synthesize emerging literature in interventional psychiatry to inform strategy and competitive positioning.

• Develop clinical protocols, eligibility criteria, care pathways, quality standards, and safety monitoring expectations for specialty therapeutic programs.

• Oversee implementation, performance monitoring, and continuous improvement of specialty therapeutic services across applicable markets and care settings.

• Oversee training and credentialing standards for clinicians delivering interventional therapies, including structured psychotherapy integration as required by emerging FDA guidance

• Partner with Medical Leadership, Clinical Operations, Quality, Research, and Finance to ensure specialty programs are clinically sound, operationally feasible, and responsibly governed.

• Partner with legal, compliance, and operations to navigate DEA Schedule I licensing (if necessary), REMS program requirements, and state-level regulatory variation.

• Collaborate with the Director of Emerging and Digital Therapeutics on data collection and outcomes measurement frameworks for interventional programs.

• Monitor outcomes, adverse events, utilization trends, patient experience, and effectiveness measures to guide program improvement and scale decisions.

• Build relationships with academic institutions, research organizations, specialty therapy centers, and external experts to inform clinical strategy and evidence generation.

This role receives strategic direction from the Senior Leader, Psychiatric Excellence & Emerging Therapeutics and independently leads development of specialty therapeutic strategy, clinical standards, program design, and outcome measurement recommendations. The role makes day-to-day decisions…